BusinessAGTC Announces Data Evaluating Novel AAV-Based Gene Therapy as a Potential Treatment for Alpha-1 Antitrypsin (AAT) DeficiencyBy Nasdaq OMXJan 20, 2016, 12:01 PM UTC